Literature DB >> 7929698

Elevated numbers of gamma-delta (gamma delta+) T lymphocytes in children with immune thrombocytopenic purpura.

R E Ware1, T A Howard.   

Abstract

Immune thrombocytopenic purpura (ITP) in childhood is a heterogeneous clinical disorder characterized by immune-mediated platelet destruction. Although generally considered to involve autoreactive B lymphocytes which produce antiplatelet antibodies, there is increasing evidence that T lymphocytes also play an important role in this autoimmune process. We studied 11 children with acute ITP and 19 children with chronic ITP and observed elevated numbers of TCR gamma delta+ T lymphocytes in several patients. In the three children with the highest elevations (TCR gamma delta+/CD3+ percentage ranging from 37.8 to 48.1% at initial evaluation), the expanded cell population exclusively expressed the surface V delta 2/V gamma 9 heterodimer and had enhanced in vitro proliferation to mycobacterial extracts and IL-2. Analysis of the nucleotide sequences used by these TCR gamma delta+ cells demonstrated a diverse set of VDDJC gene rearrangements, indicating polyclonal expansion of cells reminiscent of a superantigen response. There was a close correlation between the number of TCR gamma delta+ T lymphocytes and the degree of thrombocytopenia in each patient. TCR gamma delta+ T lymphocytes may be important in the pathogenesis of immune-mediated platelet destruction in some children with ITP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929698     DOI: 10.1007/bf01552310

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  47 in total

Review 1.  The molecular immunology of human platelet proteins.

Authors:  T J Kunicki; P J Newman
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

Review 2.  The structure, function, and molecular genetics of the gamma/delta T cell receptor.

Authors:  D H Raulet
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Induction of T cell CD7 gene transcription by nonmitogenic ionomycin-induced transmembrane calcium flux.

Authors:  R E Ware; M K Hart; B F Haynes
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

5.  Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia.

Authors:  M Carbonari; M Cherchi; R Paganelli; G Giannini; E Galli; C Gaetano; C Papetti; M Fiorilli
Journal:  N Engl J Med       Date:  1990-01-11       Impact factor: 91.245

6.  Increase in TCR gamma delta T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis.

Authors:  M R Jacobs; B F Haynes
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

7.  Expansion of a unique subpopulation of cytotoxic T cells that express a C alpha V delta 1 T-cell receptor gene in a patient with severe persistent neutropenia.

Authors:  I Bank; M Book; L Cohen; A Kneller; E Rosental; M Pras; I B Bassat; A Ben-Nun
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

8.  Variable gene usage of T cell receptor gamma- and delta-chain transcripts expressed in synovia and peripheral blood of patients with rheumatoid arthritis.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Analysis of T cells bearing different isotypic forms of the gamma/delta T cell receptor in patients with systemic autoimmune diseases.

Authors:  R Gerli; E Agea; A Bertotto; R Tognellini; L Flenghi; F Spinozzi; A Velardi; F Grignani
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

10.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  5 in total

1.  Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells.

Authors:  Baijun Fang; Ling Mai; Ning Li; Yongping Song
Journal:  Stem Cells Dev       Date:  2011-08-12       Impact factor: 3.272

2.  T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.

Authors:  P F Fogarty; M E Rick; W Zeng; A M Risitano; C E Dunbar; J B Bussel
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

3.  Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Chengshan Guo; Xiaoxia Chu; Yan Shi; Weidong He; Lizhen Li; Lin Wang; Yingxue Wang; Jun Peng; Ming Hou
Journal:  J Clin Immunol       Date:  2007-07-06       Impact factor: 8.317

4.  Idiopathic thrombocytopenic purpura: better therapeutic responses of patients with B- or T-cell clonality than patients without clonality.

Authors:  J Kim; C J Park; H S Chi; M J Kim; J J Seo; H N Moon; T T Ghim; S W Kim; J H Lee; G H Lee; J S Lee
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

5.  A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.

Authors:  Jean-Pierre de Villartay; Annick Lim; Hamoud Al-Mousa; Sophie Dupont; Julie Déchanet-Merville; Edith Coumau-Gatbois; Marie-Lise Gougeon; Arnaud Lemainque; Céline Eidenschenk; Emmanuelle Jouanguy; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Françoise Le Deist
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.